Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Details for Patent: 5,969,156

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,969,156
Title: Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
Abstract:Crystalline forms of atorvastatin and hydrates thereof are useful hypolipidemic and hypocholesterolemic agents.
Inventor(s): Briggs; Christopher A. (Holland, MI), Jennings; Rex A. (Holland, MI), Wade; Robert (Holland, MI), Harasawa; Kikuko (Sagamihara, JP), Ichikawa; Shigeru (Machida, JP), Minohara; Kazuo (Sagamihara, JP), Nakagawa; Shinsuke (Sagamihara, JP)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:08/945,812
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,969,156
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 5,969,156

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,969,156

PCT Information
PCT FiledJuly 08, 1996PCT Application Number:PCT/US96/11368
PCT Publication Date:February 06, 1997PCT Publication Number: WO97/03959

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.